Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Premarket Approval (PMA)
  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
Note: This medical device record is a PMA supplement. A supplement may have changed the device description/function or indication from that approved in the original PMA. Be sure to look at the original PMA record for more information.
 
DeviceRevanesse Ultra (Revanesse Versa)
Generic NameImplant, dermal, for aesthetic use
ApplicantPROLLENIUM MEDICAL TECHNOLOGIES INC.
138 INDUSTRIAL PARKWAY NORTH
AURORA L4G 4
PMA NumberP160042
Supplement NumberS001
Date Received08/14/2017
Decision Date10/02/2017
Product Code LMH 
Advisory Committee General & Plastic Surgery
Clinical TrialsNCT02984878
Supplement TypeNormal 180 Day Track No User Fee
Supplement Reason Labeling Change - Indications/instructions/shelf life/tradename
Expedited Review Granted? No
Combination ProductNo
Approval Order Statement  
Approval for a name change from Revanesse Ultra to Revanesse Versa.
-
-